Odylia Therapeutics

Odylia is a nonprofit dedicated to accelerating treatments for rare diseases through two core initiatives: the Odylia Pipeline and Brydge Solutions. Our internal pipeline includes three gene therapy programs. Through Brydge Solutions, we offer drug development expertise to the broader rare disease community, enabling progress through flexible and collaborative partnerships. We measure success through shortened timelines, lower costs, and fewer terminated programs in the rare disease space.